Abbott Laboratories Share Price Deutsche Boerse AG
Stocks
ABL0
CA0028221046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
07:03:14 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 11.40 EUR | 0.00% |
|
-3.39% | -14.93% |
| 09-08 | Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm | DJ |
| 09-08 | Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms | CI |
| Market Cap | 176B 152B 144B 130B 245B 16,854B 246B 1,705B 657B 8,567B 662B 648B 27,071B | P/E 2026 * |
28.9x | P/E 2027 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 200B 173B 164B 148B 278B 19,142B 280B 1,936B 746B 9,730B 752B 736B 30,744B | EV / Sales 2026 * |
3.99x | EV / Sales 2027 * | 3.62x |
| Free-Float |
86.16% | Yield 2026 * |
2.52% | Yield 2027 * | 2.69% |
| Markets | Quality | ||
|---|---|---|---|
Deutsche Boerse AG
| ABL0 | Delayed | |
Toronto S.E.
| ABT | Delayed |
Last Transcript : Abbott Laboratories
| 1 week | -3.39% | ||
| Current month | -5.79% | ||
| 1 month | -4.20% | ||
| 3 months | +17.53% | ||
| 6 months | -9.52% | ||
| Current year | -14.93% |
| 1 week | 11.4 |  | 11.8 |
| 1 month | 11.4 | | 12.6 |
| Current year | 9.2 | | 14.8 |
| 1 year | 9.2 | | 15.1 |
| 3 years | 9.2 | | 16 |
| 5 years | 9.2 | | 16 |
| 10 years | 9.2 | | 16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.39% | - | - | 176B | |
| -1.36% | -5.89% | -23.76% | -0.44% | 176B | |
| -0.72% | -3.41% | -3.26% | +12.32% | 116B | |
| +0.19% | -2.83% | +6.30% | +80.17% | 61.36B | |
| -1.92% | -6.01% | +7.05% | +38.44% | 49.42B | |
| +0.81% | -3.73% | -4.81% | -32.56% | 48.44B | |
| -1.75% | -5.54% | +8.93% | -20.82% | 31.33B | |
| +0.43% | -11.10% | - | - | 28.54B | |
| +0.58% | +1.84% | +36.58% | -12.08% | 24.37B | |
| +0.49% | -7.65% | -13.30% | +3.79% | 21.57B | |
| Average | -0.33% | -5.08% | +1.72% | +8.60% | 61.98B | |
| Weighted average by Cap. | -0.53% | -4.90% | -6.02% | +10.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 43.3B 40.99B 37.13B 69.62B 4,797B 70.1B 485B 187B 2,438B 188B 184B 7,704B | 54.53B 47.03B 44.52B 40.33B 75.61B 5,210B 76.14B 527B 203B 2,648B 205B 200B 8,367B |
| Net income | 6.3B 5.44B 5.15B 4.66B 8.74B 602B 8.8B 60.9B 23.48B 306B 23.66B 23.15B 967B | 7.98B 6.88B 6.51B 5.9B 11.06B 762B 11.14B 77.08B 29.72B 387B 29.95B 29.3B 1,224B |
| Net Debt | 23.94B 20.65B 19.55B 17.7B 33.2B 2,287B 33.43B 231B 89.18B 1,163B 89.87B 87.92B 3,673B | 20.96B 18.08B 17.11B 15.5B 29.06B 2,002B 29.26B 202B 78.07B 1,018B 78.67B 76.97B 3,216B |
| Date | Price | Change |
|---|---|---|
| 11/09/26 | €11.40 | 0.00% |
| 10/09/26 | €11.40 | 0.00% |
| 09/09/26 | €11.40 | -3.39% |
| 08/09/26 | €11.80 | 0.00% |
| 07/09/26 | €11.80 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL0 Stock
Select your edition
All financial news and data tailored to specific country editions
